929217-81-2

Basic information

• Product Name: {[1-(2-amino-ethylcarbamoyl)-2-(4-nitro-phenyl)-ethylcarbamoyl]-methyl}-carbamic acid tert-butyl ester
• Synonyms: {[1-(2-amino-ethylcarbamoyl)-2-(4-nitro-phenyl)-ethylcarbamoyl]-methyl}-carbamic acid tert-butyl ester
• CAS NO: 929217-81-2
• Molecular Weight: 409.442
• Mol File: 929217-81-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: {[1-(2-amino-ethylcarbamoyl)-2-(4-nitro-phenyl)-ethylcarbamoyl]-methyl}-carbamic acid tert-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: {[1-(2-amino-ethylcarbamoyl)-2-(4-nitro-phenyl)-ethylcarbamoyl]-methyl}-carbamic acid tert-butyl ester(929217-81-2)
• EPA Substance Registry System: {[1-(2-amino-ethylcarbamoyl)-2-(4-nitro-phenyl)-ethylcarbamoyl]-methyl}-carbamic acid tert-butyl ester(929217-81-2)

Safety Data

• Hazardous Substances Data: 929217-81-2(Hazardous Substances Data)

Upstream product

• 929217-80-1 2-(2-tert-butoxycarbonylamino-acetylamino)-3-(4-nitro-phenyl)-propionic acid methyl ester 
• 107-15-3 ethylenediamine 
• 18185-77-8 tert-butyloxycarbonylglycine imidazolide 
• 17193-40-7 (+)-Methyl 2-amino-3-(4-nitrophenyl)propionate hydrochloride 
• 85317-52-8 methyl 2-amino-3-(4-nitrophenyl)propionate 
• 1991-83-9 4-nitrophenylalanine 
• 4530-20-5 BOC-glycine 

Downstream Products

• 929217-83-4 3-(4-nitrobenzyl)triethylenetetraamine 
• 929217-82-3 N-(2-aminoethyl)-glycyl 4-nitriphenylalaninamide 

Relevant articles and documents

Synthesis and evaluation of a novel samarium-153 bifunctional chelating agent for radioimmunotargeting applications

A new bifunctional chelating agent (BCA), 3-(4-isothiocyanatobenzyl) triethylenetetraaminehexaacetic acid (9), has been synthesized in fast and easy conditions. An improved synthesis of its position isomer 1-(4- isothiocyanatobenzyl)triethylenetetraaminehexaacetic acid (19) is also described. Stability in serum media of the two corresponding aminobenzyl derivatives-samarium-153 complexes, respectively, 3-(4-aminobenzyl) triethylenetetraaminehexaacetic acid-samarium-153 and 1-(4-aminobenzyl) triethylenetetraaminehexaacetic acid-samarium-153, have been evaluated. The 3-(4-aminobenzyl)triethylenetetraaminehexaacetic acid complex revealed excellent stability in serum media, and therefore 3-(4-isothiocyanatobenzyl) triethylenetetraaminehexaacetic acid (9) appears useful for future in vivo radioimmunotherapy investigations. Copyright